secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001650664-24-000081
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine director Akshay Vaishnaw resigns from Board effective June 30, 2024
--------------------------------------------------------------------------------

- Akshay Vaishnaw submitted resignation on June 27, 2024; effective June 30, 2024.
- Resignation not due to any disagreement with Company’s operations, policies, or practices.
- No replacement or additional board changes announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000165066424000081/0001650664-24-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000165066424000081/edit-20240627.htm
  HTML page:      https://secwatch.observer/filing/0001650664-24-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer